A world leader in the field of in vitro diagnostics for 60 years, bioMérieux provides diagnostic solutions (systems, reagents, software) that assist is identifying potential sources of infectious disease to improve patient health and ensure consumer safety. Fast and actionable diagnostics are essential for identifying the possible cause of infections in immunocompromised patients. bioMérieux’s syndromic approach identifies a broad grouping of probable pathogens in one rapid test, maximizing the chance of getting actionable answers in a clinically relevant timeframe.